[go: up one dir, main page]

AU2904199A - Use of human mesenchymal stem cells to induce t-cell apoptosis - Google Patents

Use of human mesenchymal stem cells to induce t-cell apoptosis

Info

Publication number
AU2904199A
AU2904199A AU29041/99A AU2904199A AU2904199A AU 2904199 A AU2904199 A AU 2904199A AU 29041/99 A AU29041/99 A AU 29041/99A AU 2904199 A AU2904199 A AU 2904199A AU 2904199 A AU2904199 A AU 2904199A
Authority
AU
Australia
Prior art keywords
induce
stem cells
mesenchymal stem
cell apoptosis
human mesenchymal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29041/99A
Inventor
Kevin R. Mcintosh
Joseph D. Mosca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osiris Therapeutics Inc
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Publication of AU2904199A publication Critical patent/AU2904199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4225—Growth factors
    • A61K40/4228—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU29041/99A 1998-04-03 1999-03-12 Use of human mesenchymal stem cells to induce t-cell apoptosis Abandoned AU2904199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8053398P 1998-04-03 1998-04-03
US60080533 1998-04-03
PCT/US1999/005349 WO1999051247A1 (en) 1998-04-03 1999-03-12 Use of human mesenchymal stem cells to induce t-cell apoptosis

Publications (1)

Publication Number Publication Date
AU2904199A true AU2904199A (en) 1999-10-25

Family

ID=22157999

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29041/99A Abandoned AU2904199A (en) 1998-04-03 1999-03-12 Use of human mesenchymal stem cells to induce t-cell apoptosis

Country Status (2)

Country Link
AU (1) AU2904199A (en)
WO (1) WO1999051247A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
CA2564679C (en) 2004-03-22 2015-06-23 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
EP2624846A2 (en) 2010-10-08 2013-08-14 Osiris Therapeutics, Inc. Nanoparticle-loaded cells
KR20200088445A (en) 2017-11-22 2020-07-22 메조블라스트 인터내셔널 에스에이알엘 Cell composition and treatment method I

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3982588B2 (en) * 1992-08-10 2007-09-26 アメリカ合衆国 Interleukin-4 stimulated T lymphocyte cell death
DE4421391C1 (en) * 1994-06-18 1995-11-30 Gsf Forschungszentrum Umwelt Use of antibodies against T cells for prolonged immunosuppression

Also Published As

Publication number Publication date
WO1999051247A1 (en) 1999-10-14

Similar Documents

Publication Publication Date Title
AU2730497A (en) Cryopreservation and extensive subculturing of human mesenchymal stem cells
AU4094099A (en) Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
AU2469299A (en) Purified populations of stem cells
AU1478000A (en) (in utero) transplantation of human mesenchymal stem cells
EP0832188A4 (en) Chemically defined medium for human mesenchymal stem cells
AU6372900A (en) Linkage of agents to tissue
AU5761700A (en) Cold-plasma treatment of seeds to remove surface materials
AU2002352443A1 (en) Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3
AU2002306865A1 (en) Generation of multipotent central nervous system stem cells
PL335409A1 (en) Self-regulating apoptosis of inflammatory cells owing to genotherapy
AU4184299A (en) Human apoptosis associated proteins
AUPO557497A0 (en) Improvements to underpants
AU2002235168A1 (en) Targeting pluripotent stem cells to tissues
AU2197897A (en) Use of delta-like protein to inhibit the differentiation of stem cells
AU3623700A (en) Apoptosis inducing molecule ii and methods of use
AU2904199A (en) Use of human mesenchymal stem cells to induce t-cell apoptosis
AU2001256555A1 (en) New inhibotor of apoptosis of nerve cells
AU2001247880A1 (en) Methods to prepare and use epidermal stem cells
AU2972199A (en) Apoptosis inducing molecule ii and methods of use
GB9809355D0 (en) Improvements relating to blood sampling devices
AU4647300A (en) Skin care compositions containing combination of skin care actives
AU5570899A (en) Purified human papillomavirus
AU7104500A (en) Use of rafp to inhibit or prevent apoptosis
AU2998300A (en) Genetically altered mesenchymal stem cells and methods of use thereof
AU2935899A (en) Improvements to disposable diapers

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase